Arcus Biosciences (RCUS) Stock: Buy, Sell, or Hold?
RCUS - Arcus Biosciences, Inc.
$19.36
0.26 (1.36%)
▲
5d:
-15.16%
30d:
-26.64%
90d:
-31.88%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Oct 27, 2026
3d
Get Alerted When RCUS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: RCUS is down 15.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: RCUS is down 15.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: RCUS is currently trading at $19.36, which is considered oversold relative to its 30-day fair value range of $22.34 to $25.91.
Technical Outlook: Technically, RCUS is in a downtrend. Immediate support is located at $17.43, while resistance sits at $24.73.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $41.69 (+115.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, RCUS is in a downtrend. Immediate support is located at $17.43, while resistance sits at $24.73.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $41.69 (+115.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$22.34 -
$25.91
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
Protect Your Profits
Holding RCUS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 115.4% below Wall St target ($41.69)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$22.34 -
$25.91
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$17.43
Resistance Level
$24.73
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.20
Wall Street Target
$41.69
(+115.4%)
Revenue Growth (YoY)
-74.4%
Share & Embed Analysis
Last updated: October 23, 2026 6:23 AM ET
Data refreshes hourly during market hours. Next update: 7:23 AM
Data refreshes hourly during market hours. Next update: 7:23 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RCUS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 68 BUY |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 71 BUY |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
20 analysts |
$17 | 60 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
14 analysts |
$153 | 68 BUY |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$108 | 60 BUY |
Advanced RCUS Option Strategies
Professional options setups generated by AI based on today's RCUS price and gamma walls.
